SCHMC

A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer

Metadata Downloads
All Author(s)
J. Yun ; H. J. Kim ; K. H. Kim ; S. H. Kim ; S.-C. Lee ; S. B. Bae ; C. K. Kim ; N. Lee ; K. T. Lee ; S. K. Park ; J.-H. Won ; D. S. Hong ; H. S. Park ; H. J. Choi ; J. H. Moon
Intsitutional Author(s)
김한조; 이상철; 배상병; 이규택
Issued Date
2014
Type
Conference
Conference Name
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference Date
41789
dc_citation_conferenceCountry
Chicago, IL, United States
Citation Publisher
American Society of Clinical Oncology
Citation Title
Journal of Clinical Oncology. Volume 32, Number 15_suppl
Citation Start Page
e15260
Citation End Page
e15260
Language(ISO)
eng
DOI
10.1200/jco.2014.32.15_suppl.e15260
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4534
Appears in Collections:
종양혈액내과 > 2. Conference Papers
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.